Eagle Pharmaceuticals, Inc. (EGRX) financial statements (2021 and earlier)

Company profile

Business Address 50 TICE BOULEVARD, SUITE 315
WOODCLIFF LAKE, NJ 07677
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10311079115537943
Cash and cash equivalents10311079115537923
Short-term investments      20
Receivables5148665442267
Inventory, net of allowances, customer advances and progress billings87853151
Inventory87853151
Prepaid expense05610210
Other current assets2101000
Other undisclosed current assets2945911
Total current assets:16617916418910912253
Noncurrent Assets
Property, plant and equipment2227320
Intangible assets, net (including goodwill)5355586373  
Goodwill4040404040  
Intangible assets, net (excluding goodwill)1316182333  
Regulated entity, other noncurrent assets  11   
Deferred income tax assets1514
Other noncurrent assets17410000
Other undisclosed noncurrent assets  131029  
Total noncurrent assets:8775758110520
TOTAL ASSETS:25325523927021412553
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30343327402814
Accounts payable6510121544
Accrued liabilities24282415252410
Debt8565   
Business combination, contingent consideration, liability   151  
Deferred revenue and credits  67
Total current liabilities:38394047413420
Noncurrent Liabilities
Long-term debt and lease obligation25343843   
Long-term debt, excluding current maturities25343843   
Liabilities, other than long-term debt43 122  
Other liabilities43     
Business combination, contingent consideration, liability   122  
Total noncurrent liabilities:2937384422  
Total liabilities:67757891633420
Stockholders' equity
Stockholders' equity attributable to parent1861791611791519033
Common stock0000000
Treasury stock, value(204)(172)(154)(81)(37)  
Additional paid in capital305279256234214197137
Retained earnings (accumulated deficit)84735826(26)(107)(104)
Total stockholders' equity:1861791611791519033
TOTAL LIABILITIES AND EQUITY:25325523927021412553

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2014
Revenues1881962132371896619
Revenue, net2371896619
Cost of revenue(34)(48)(42)(34)(34)(16)(12)
Cost of goods and services sold(34)(48)(42)(34)(34)  
Other undisclosed gross profit (13)     
Gross profit:154135171203155517
Operating expenses(121)(126)(177)(163)(136)(64)(38)
Other undisclosed operating income 134234341612
Operating income (loss):33223774533(19)
Nonoperating income (expense)(10)0(3)(1)00(1)
Investment income, nonoperating1200000
Other nonoperating income (expense)(8)1    0
Interest and debt expense(3)(3)(3)(0)(0)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:20193173533(19)
Other undisclosed income from continuing operations before income taxes3330000
Income (loss) from continuing operations before income taxes:23223473533(19)
Income tax expense (benefit)(11)(8)(2)(21)28(0)1
Net income (loss) attributable to parent:12143252813(18)
Preferred stock dividends and other adjustments      (2)
Net income (loss) available to common stockholders, diluted:12143252813(20)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2014
Net income (loss):12143252813(18)
Comprehensive income (loss), net of tax, attributable to parent:12143252813(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: